FEDERATED HERMES, INC.

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in LENZ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$27,814

-$974,362 QoQ

Shares Held

4,897

-92.2% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#101

of 143 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. LENZ ranks #114 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,814	4,897	-92.2%	Shares	Defined	2026-08-12
2025-12-31	$1,002,176	62,636	+139091.1%	Shares	Defined	2026-02-12
2024-12-31	$1,299	45	—	Shares	Defined	2025-02-13
2023-06-30 GRPH	—	408,157	-0.4%	Shares	Defined	2023-08-14
2023-03-31 GRPH	—	409,962	-61.3%	Shares	Defined	2023-05-08
2022-12-31 GRPH	—	1,058,501	+0.0%	Shares	Defined	2023-02-13
2022-09-30 GRPH	—	1,057,983	+0.2%	Shares	Defined	2022-11-14
2022-06-30 GRPH	—	1,056,308	0.0%	Shares	Defined	2022-09-16
2022-03-31 GRPH	—	1,056,308	0.0%	Shares	Defined	2022-05-13
2021-12-31 GRPH	—	1,056,308	0.0%	Shares	Defined	2022-02-14
2021-09-30 GRPH	—	1,056,308	+62.5%	Shares	Defined	2021-11-15
2021-06-30 GRPH	—	650,000	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.